Literature DB >> 23633103

Association of Pro12Ala (rs1801282) variant of PPAR gamma with rheumatoid arthritis in a Pakistani population.

Syed Fazal Jalil1, Iltaf Ahmed, Zeeshan Gauhar, Mushtaq Ahmed, Javaid M Malik, Peter John, Attya Bhatti.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) belongs to a receptor superfamily of ligand-activated transcription factors, encoded by PPARG gene. Role of PPARγ has been well established in variety of metabolic disorders and in regulation of inflammation. In the present study, we aimed to investigate the association of PPARG (Pro12Ala; rs1801282) in clinically definite Pakistani Rheumatoid Arthritis (RA) patients and matching controls. The genotypes of the Pro12Ala variant in the PPARG were determined in a sample of 300 Pakistanis, including 150 RA cases and 150 controls. The genotyping was performed using Amplification Refractory Mutation System-Polymerase Chain Reaction (ARMS-PCR) method, and the data was analyzed through Graphpad Prism 5 V software. Allele-specific primer set (two forward: PPARG-F1, PPARG-F2 and a common reverse primer: PPARG-R) was used for amplification, and the product was resolved on 2 % agarose gel. The CC (ProPro) genotype has higher frequency in controls than RA cases [75 (50.0 %) vs. 51 (34.0 %)], whereas the CG (ProAla) genotype has relatively same frequencies in both cases and controls [72 (48.0 %) vs. 70 (46.6 %)]. However, significantly higher frequency of GG (AlaAla) genotype was observed in cases [27 (18.0 %) vs. 5 (3.3 %); χ2 18.54; p < 0.0001]. Furthermore, the minor allele G has significantly higher allele frequency in cases having same trend and direction of association (OR 1.991(1.412-2.808); p < 0.0001). These observations suggest that Pro12Ala (rs1801282), a coding variant in the PPARG gene, is associated with Rheumatoid Arthritis in Pakistanis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23633103     DOI: 10.1007/s00296-013-2768-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

Review 1.  The genetics revolution and the assault on rheumatoid arthritis.

Authors:  M F Seldin; C I Amos; R Ward; P K Gregersen
Journal:  Arthritis Rheum       Date:  1999-06

Review 2.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

3.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.

Authors:  A J MacGregor; H Snieder; A S Rigby; M Koskenvuo; J Kaprio; K Aho; A J Silman
Journal:  Arthritis Rheum       Date:  2000-01

4.  Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.

Authors:  J Masugi; Y Tamori; H Mori; T Koike; M Kasuga
Journal:  Biochem Biophys Res Commun       Date:  2000-02-05       Impact factor: 3.575

5.  A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

Authors:  C G Su; X Wen; S T Bailey; W Jiang; S M Rangwala; S A Keilbaugh; A Flanigan; S Murthy; M A Lazar; G D Wu
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 6.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

7.  Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.

Authors:  Laura Frederiksen; Kasper Brødbaek; Mogens Fenger; Torben Jørgensen; Knut Borch-Johnsen; Sten Madsbad; Søren A Urhammer
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

8.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

9.  Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis.

Authors:  Khalid Z Al-Shali; Andrew A House; Anthony J G Hanley; Hafiz M R Khan; Stewart B Harris; Bernard Zinman; Mary Mamakeesick; Aaron Fenster; J David Spence; Robert A Hegele
Journal:  Stroke       Date:  2004-07-29       Impact factor: 7.914

10.  The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma-2 gene (PPARγ2) is associated with increased risk of coronary artery disease: a meta-analysis.

Authors:  Zhijun Wu; Yuqing Lou; Wei Jin; Yan Liu; Lin Lu; Guoping Lu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more
  4 in total

1.  Development of ARMS-PCR assay for genotyping of Pro12Ala SNP of PPARG gene: a cost effective way for case-control studies of type 2 diabetes in developing countries.

Authors:  Mehboob Islam; Fazli Rabbi Awan; Shahid Mahmood Baig
Journal:  Mol Biol Rep       Date:  2014-07-26       Impact factor: 2.316

2.  Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Genet Test Mol Biomarkers       Date:  2014-04-03

3.  Quantitative PPARγ expression affects the balance between tolerance and immunity.

Authors:  Ya-Hui Liu; Yau-Sheng Tsai; Shih-Chieh Lin; Nan-Shih Liao; Ming-Shiou Jan; Chung-Tiang Liang; Shih-Wen Hsu; Wen-Chung Chen; Junne-Ming Sung; Nobuyo Maeda; Pei-Jane Tsai
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

4.  PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders.

Authors:  Bogna Grygiel-Górniak; Iwona Ziółkowska-Suchanek; Elżbieta Kaczmarek; Maria Mosor; Jerzy Nowak; Mariusz Puszczewicz
Journal:  Clin Interv Aging       Date:  2018-03-22       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.